BioDirection Receives Breakthrough Device Designation from FDA for Tbit(TM) System

Portable nanotechnology biosensor has the potential to predict positive CT scans following traumatic brain injury BOSTON, Feb. 11, 2019 -- (Healthcare Sales & Marketing Network) -- BioDirection, Inc., a privately held medical device company developing ... Devices, Diagnostics, Neurology, FDA BioDirection, Tbit, traumatic brain injury

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2044749

Source: HSMN NewsFeed - February 11, 2019 Category: Pharmaceuticals Source Type: news